How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

LE

NASDAQ:LEXX
Get a brief AI stock analysisSaves ~ 15 minutes of your time

LE

Lexaria Bioscience CorpNASDAQ LEXX Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is LEXX undervalued compared to its fair value?

The fair value of LEXX stock is hidden USD. Relative to the market price of 2.73 USD Lexaria Bioscience Corp is hidden.

Lexaria Bioscience Corp. is a biotechnology company, which engages in the provision of active pharmaceutical ingredients through its DehydraTECH drug delivery technology. The company is headquartered in Kelowna, British ...[More about valuation]

Lexaria Bioscience Corp Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.044 $B

Price:

2.73 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.06

FINANCIALS

Lexaria Bioscience Corp financial for reporting period

Income Statement

0.0001 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0007 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0006 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.0001 B 100%
0.0001 B 100%
-0.0007 B -461%
-0.0006 B -448%

Balance Sheet

0.0064 B
0.0065 B

Financial Position Analysis

Assets

0.0064 B
Current Assets
0.0054 B
Total non-current assets
0.0009 B

Total current liabilities
0.0001 B
Total non-current liabilities
-0.0003 B

Cash Flow Statement

-0.0007 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0006 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Lexaria Bioscience Corp fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-123 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-428 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-119 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is LEXX attractive for investment based on fundamental analysis?

LEXX stock rating is hidden. Lexaria Bioscience Corp is a hidden by Eyestock methodology.

Get LEXX Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-1 408

Gross Margin:

96

CFO / Debt ratio:

hidden

Current ratio:

9.472

Debt / Equity ratio:

ROE:

-123

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

LEXX analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for LEXX to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Lexaria Bioscience Corp competitors

LL

LLY

Eli Lilly and Co

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs ...

Discover

NO

NOVO B.CO

Novo Nordisk A/S

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged i...

Discover

JN

JNJ

Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. The company is headquartered in Ne...

Discover

Lexaria Bioscience Corp dividends

LEXX dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About LEXX stock

About the company Lexaria Bioscience Corp

Market cap $B

0.044

Dividend yield

Shares outstanding

5.951 B

Lexaria Bioscience Corp. is a biotechnology company, which engages in the provision of active pharmaceutical ingredients through its DehydraTECH drug delivery technology. The company is headquartered in Kelowna, British Columbia and currently employs 7 full-time employees. The company went IPO on 2009-10-28. The firm is a global innovator in drug delivery platforms. The firm operates through two segments: Intellectual Property and Products. The Company’s patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting oral delivery. The Company’s operations involve the development and usage, including licensing, of its DehydraTECH Technology. The firm operates a licensed in-house research laboratory and holds an intellectual property portfolio with approximately 27 patents granted and roughly 50 patents pending worldwide. The Company’s subsidiaries include Lexaria CanPharm ULC, Lexaria CanPharm Holdings Corp., PoViva Corp., Lexaria Hemp Corp., Kelowna Management Services Corp., Lexaria Nicotine LLC and Lexaria Pharmaceutical Corp.

LEXX profile

  • Ticker

    LEXX

  • Country

    Canada

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    28 October 2009

  • Sector

    Healthсare

  • Industry

    Pharmaceuticals

  • Employees

    7

  • City

    Kelowna

  • Address

    100 - 740 Mccurdy Road

  • Cusip

    52886N406